Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 119
Phase 23

Trial Status

Completed16
Recruiting10
Terminated9

Role Distribution

Principal Investigator35
PI Rate100%

Activity Timeline

Clinical Trials (20)

NCT07686393Phase 1Recruiting
PET Imaging of Noradrenergic Transmission in the Brain
Healthy
PrincipalinvestigatorStart date: 2026-08-14
NCT07625345Phase 1Recruiting
Evaluation of [11C]ZTP-1 to Image PDE4B
Healthy
PrincipalinvestigatorStart date: 2026-07-01
NCT07027839Phase 1Recruiting
Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)
Alcohol Use Disorder
PrincipalinvestigatorStart date: 2025-12-11
NCT06920628Phase 1Recruiting
PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Long COVIDPost Acute Sequelae of COVID-19
PrincipalinvestigatorStart date: 2025-06-18
NCT06874205Phase 1Recruiting
Assessment of 11C-JMJ-129 for Imaging PDE4D in Brain and Whole Body of Healthy Volunteers
Healthy
PrincipalinvestigatorStart date: 2025-04-11
NCT06795581Phase 1Recruiting
PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder
Alcohol Use Disorder
PrincipalinvestigatorStart date: 2025-03-20
NCT05703685Phase 1Recruiting
[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET
Depression
PrincipalinvestigatorStart date: 2023-06-22
NCT05522673Phase 1Terminated
[11C]-(R)-Rolipram to Measure cAMP Signaling Before and After Ketamine
Depression
PrincipalinvestigatorStart date: 2023-02-08
NCT05062083Phase 2Terminated
PET Imaging of Cyclooxygenase in Multiple Sclerosis
Multiple Sclerosis
PrincipalinvestigatorStart date: 2022-06-07

Showing 10 of 20 trials

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Autistic DisorderAutism Spectrum DisorderAlzheimer Disease+7 more
Similarity Score9%

Marie Carmen Valenza, phD

Universidad de Granada

Related
25 trials

Shared therapeutic areas:

Mild Cognitive ImpairmentMultiple SclerosisParkinson Disease+1 more
Similarity Score3%

Ken Nedd, M.D.

GAAD Medical Research Institute Inc.

Related
20 trials

Shared therapeutic areas:

Alzheimer DiseaseDementiaMultiple Sclerosis+1 more
Similarity Score3%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

HealthyHealthy VolunteersArthritis, Rheumatoid
Similarity Score3%

Suman Sheraz, PhD*

Riphah International University

Related
21 trials

Shared therapeutic areas:

Autism Spectrum DisorderHealthyHealthy Volunteers
Similarity Score3%

Ana-Maria Vranceanu, PhD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Mild Cognitive ImpairmentDementiaNervous System Diseases
Similarity Score3%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

Multiple SclerosisArthritis, Rheumatoid
Similarity Score2%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

Multiple SclerosisHealthy
Similarity Score2%

Urielle Desalbres

Assistance Publique Hôpitaux de Marseille

Related
71 trials

Shared therapeutic areas:

Parkinson DiseaseSchizophrenia
Similarity Score2%

Nieto Luis, Master

Site Coordinator of United Medical Group located in Miami

Related
37 trials

Shared therapeutic areas:

Parkinson DiseaseAutistic Disorder
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (35)

Showing 20 of 35 trials

NCT07686393Phase 1PrincipalInvestigator

PET Imaging of Noradrenergic Transmission in the Brain

Healthy
Recruiting
NCT07625345Phase 1PrincipalInvestigator

Evaluation of [11C]ZTP-1 to Image PDE4B

Healthy
Recruiting
NCT07027839Phase 1PrincipalInvestigator

Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)

Alcohol Use Disorder
Recruiting
NCT06920628Phase 1PrincipalInvestigator

PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

Long COVIDPost Acute Sequelae of COVID-19
Recruiting
NCT06874205Phase 1PrincipalInvestigator

Assessment of 11C-JMJ-129 for Imaging PDE4D in Brain and Whole Body of Healthy Volunteers

Healthy
Recruiting
NCT06795581Phase 1PrincipalInvestigator

PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder

Alcohol Use Disorder
Recruiting
NCT05703685Phase 1PrincipalInvestigator

[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET

Depression
Recruiting
NCT05522673Phase 1PrincipalInvestigator

[11C]-(R)-Rolipram to Measure cAMP Signaling Before and After Ketamine

Depression
Terminated
NCT05564429Phase 1PrincipalInvestigator

[18F]SF12051 for Imaging the 18-kDa Translocator Protein (TSPO) in Brain and Whole Body of Healthy Subjects

Healthy
Terminated
NCT05062083Phase 2PrincipalInvestigator

PET Imaging of Cyclooxygenase in Multiple Sclerosis

Multiple Sclerosis
Terminated
NCT04396873Phase 1PrincipalInvestigator

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

ALSAlzheimer's DiseaseDementia+2 more
Recruiting
NCT04582916Phase 1PrincipalInvestigator

PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)

Depression
Recruiting
NCT03958630Phase 1PrincipalInvestigator

PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel Translocator Protein (TSPO) Radioligand

Dementia
Terminated
NCT03912428Phase 1PrincipalInvestigator

Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions

Healthy VolunteersInflammatoryMyositis+1 more
Terminated
NCT03861000Phase 1/2PrincipalInvestigator

Title: Evaluation of a Novel PET Radioligand for Phosphodiesterase-4D (PDE4D)

Depression
Completed
NCT02743377Phase 1/2PrincipalInvestigator

PET Imaging of Phosphodiesterase-4 (PDE4) in Brain and Peripheral Organs of McCune-Albright Syndrome

Nervous System Disease
Completed
NCT03324646PrincipalInvestigator

Evaluation of a Novel PET Radioligand to Image Cyclooxygenase-1 (COX-1)

Normal Physiology
Completed
NCT00362843PrincipalInvestigator

Protein Synthesis in the Brain of Patients With Fragile X Syndrome

Fragile X SyndromeHealthy Volunteers
Completed
NCT00598390Phase 1PrincipalInvestigator

PET Imaging of Cannabinoid CB1 Receptors Using [11C]MePPEP

Healthy
Completed
NCT00613119PrincipalInvestigator

PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Frontotemporal Dementia

DementiaFrontotemporal Lobar Degeneration
Completed